Latest News & Updates

Breaking News

  • 2 hours ago

  • Pharma Now Editorial Team

Supreme Court Restores Mifepristone Access via Telehealth and Mail
Breaking News
Apitoria Pharma CEO Departure Raises Supply Chain Watch Points

Pharma Now Editorial Team

Other trending news you may like to read

Supreme Court Restores Mifepristone Access via Telehealth and Mail

Supreme Court temporarily restores mifepristone access via telehealth and mail, reopening REMS compliance questions for manufacturers and pharmacies.

Pharma Now Editorial Team

Pharma Now

Apitoria Pharma CEO Departure Raises Supply Chain Watch Points

Aurobindo Pharma confirms CEO resignation at API subsidiary Apitoria Pharma, with successor search now underway.

Pharma Now Editorial Team

Pharma Now

UCB's Candid Therapeutics Deal Signals Pipeline Scale-Up Pressure

UCB acquires Candid Therapeutics, triggering technology transfer, GMP alignment, and regulatory filing reviews across both organizations.

Pharma Now Editorial Team

Pharma Now

GDUFA Type II API DMF Submissions Signal Generics Pipeline Shift

FDA data shows GDUFA Type II API DMF payments at 147 through May FY2026, tracking below recent full-year totals and signaling potential generics pipeline shifts.

Pharma Now Editorial Team

Pharma Now